Make Your Own Deter...
Health Care: Drugs
3SBio Inc. (SSRX: NASDAQ)
$13.01 -0.04 | -0.31%
05/24/12 - 04:00 PM ET
25.65K / 80.80K
Vol / Avg. Vol:13.10 / 13.05
Open / Prev. Close:12.95 - 13.19
Today's Range:9.26 - 19.00
52 Wk Range:27.69%
Performance YTD:TheStreet Rating:
Portfolios with SSRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- UserHigh Composite
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorTheStreet Ratings Top-Rated...
- Userbiotech
- UserSUPRATRADE Top 10 U.S.-List...
- Usermchish Portfolio 1
- UserRick's Port
- UserDoc Riggs
Latest SSRX Headlines from TheStreet
- 7 Stocks Climbing on High Volume 05.14.12 | 03:05 pm
- 3SBio Inc. Stock Upgraded (SSRX) 03.13.12 | 06:03 am
- 3SBio Stock Soars (SSRX) 03.09.12 | 03:03 pm
- 8 Stocks Rising on Unusual Volume 12.19.11 | 12:12 pm
- 5 Stocks Setting Up to Break Out 11.11.11 | 01:11 pm
- 3SBio Inc. Stock Downgraded (SSRX) 10.06.11 | 07:10 am
- China Drug Stocks Offer Value Remedy 02.16.10 | 11:02 am
- Friday's Asia ADR Recap 07.18.08 | 06:07 pm
- Thursday's Health Winners & Losers 03.20.08 | 03:03 pm
- Wednesday's Asia Stocks Recap 03.12.08 | 05:03 pm
Press Releases for SSRX
- 3SBio Inc. Files Annual Report On Form 20-F For Fiscal Year 2011 - PR Newswire 04.30.12 | 10:04 pm
- 3SBio Inc. Announces Changes To Its Board Of Directors - PR Newswire 03.21.12 | 10:03 am
- 3SBio And DaVita Collaborate On Dialysis Clinics In Northeastern China - PR Newswire 03.08.12 | 04:03 pm
- 3SBio Inc. To Present At The Oppenheimer & Co. 6th Annual China Dragon Conference - PR Newswire 02.07.12 | 03:02 am
- 3SBio Inc. Schedules Unaudited Fourth Quarter And Full Year 2011 Results - PR Newswire 02.03.12 | 09:02 am
- 3SBio Inc. To Present At The UBS Greater China Conference 2012 - PR Newswire 01.09.12 | 08:01 am
- 3SBio Inc. Schedules Unaudited Third Quarter 2011 Results - PR Newswire 10.20.11 | 02:10 am
- 3SBio Inc. To Hold 2011 Annual General Meeting On September 20, 2011 - PR Newswire 08.20.11 | 12:08 am
- Ascenta Therapeutics And Ascentage Pharma Sign R&D Collaboration And Regional License Agreements For Two Cancer Programs - PR Newswire 12.01.10 | 08:12 am
Partner Headlines for SSRX
- Chinese Stocks That Are Best To Own Through May - Seeking Alpha 04.10.12 | 09:04 am
- 3-S Bio Brushes Off Regulatory Threat - Seeking Alpha 03.15.12 | 08:03 am
- China Biotech In Review: GSK Explores All Paths To Increase China Presence - Seeking Alpha 03.11.12 | 07:03 am
- DaVita Collaborates with 3SBio - Analyst Blog - Zacks 03.09.12 | 06:03 pm
- UPDATE: Auriga Upgrades 3SBio to Buy, Reiterates $13 PT - Benzinga 01.18.12 | 09:01 am
- China Biotech Week in Review: Sinopharm's M&A Extends Drug Distribution Network - Seeking Alpha 01.30.11 | 07:01 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.23.10 | 09:07 am
- AMAG Pharma Inks Deal - Analyst Blog - Zacks 04.06.10 | 01:04 pm
- Narrower Q4 Loss for AMAG - Analyst Blog - Zacks 03.02.10 | 11:03 am
